AG

Anand Goyal

Active Director Director DIN 10088524
DIN 10088524 First appointment May 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since May 2023
Shareholding value •••• Premium profile

About Anand Goyal

Data last updated:

Anand Goyal is a Director at Fresenius Medical Care India Private Limited (since 2023), Director at Fresenius Medical Care Dialysis Services India Private Limited (since 2023) and Director at Regency Nephrocare Private Limited (since 2023). The companies operate in Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹1,075 Cr; the largest is Fresenius Medical Care India Private Limited at ₹1,026 Cr (FY 2025). Earlier, Anand Goyal was a Director at Srinath Nephrocare Private Limited (from 2023).

DIN 10088524
Primary Designation Director
Industry Healthcare
First Appointment 11 May 2023
Oldest Company Age 20 yrs
Largest company Fresenius Medical Care India Private Limited · ₹1,026 Cr (FY 2025)
Combined revenue ₹1,075 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 May 20232006₹1,026 Cr (FY 2025)Active
Director26 May 20232011₹37.49 Cr (FY 2023)Active
Regency Nephrocare Private Limited U85191UP2013PTC058477
Director11 May 20232013₹11.34 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Srinath Nephrocare Private Limited U85100DL2012PTC245524
Director11 May 20232012₹2.98 Cr (FY 2017)Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fresenius Medical Care India Private Limited
Srinath Nephrocare Private Limited
Regency Nephrocare Private Limited
Fresenius Medical Care Dialysis Services India Private Limited
Premium access

Shareholding and investment profile for Anand Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anand Goyal

Anand Goyal currently holds 3 directorships: Fresenius Medical Care India Private Limited (Director, since 26 May 2023, revenue ₹1,026 Cr (FY 2025)); Fresenius Medical Care Dialysis Services India Private Limited (Director, since 26 May 2023, revenue ₹37.49 Cr (FY 2023)); Regency Nephrocare Private Limited (Director, since 11 May 2023, revenue ₹11.34 Cr (FY 2025)).

Anand Goyal was first appointed on 11 May 2023 as Director at Regency Nephrocare Private Limited.

The 3 current companies of Anand Goyal that report revenue have a combined latest revenue of ₹1,075 Cr: Fresenius Medical Care India Private Limited ₹1,026 Cr (FY 2025); Fresenius Medical Care Dialysis Services India Private Limited ₹37.49 Cr (FY 2023); Regency Nephrocare Private Limited ₹11.34 Cr (FY 2025).

Anand Goyal held 1 earlier board appointment: Srinath Nephrocare Private Limited (Director, from 11 May 2023).

The current boards of Anand Goyal's companies include Ankur Garg (Fresenius Medical Care India Private Limited), Bhaskar Sunil Guha (Fresenius Medical Care India Private Limited), Krishna Chellappa (Fresenius Medical Care Dialysis Services India Private Limited), Likesh Sharma (Fresenius Medical Care Dialysis Services India Private Limited), Rekha Alex Daniel (Fresenius Medical Care Dialysis Services India Private Limited), Sujit Singh (Fresenius Medical Care Dialysis Services India Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available